Datamonitor's Pharmaceuticals - Top 5 Emerging Markets Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the Top 5 Emerging markets (Brazil, China, India, Mexico and South Africa). The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovations and potential growth areas within the market.
Scope of the Report
Contains an executive summary and data on value, volume and segmentation
Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies
Incorporates in-depth five forces competitive environment analysis and scorecards
Compares data from Brazil, China, India, Mexico and South Africa, alongside individual chapters on each country. .
Includes a five-year forecast of the industry
Highlights
The Top 5 Emerging countries contributed $46.4 billion to the global Pharmaceuticals industry in 2007, with a CAGR of 13.3% between 2004 and 2007
In 2013, the market is forecast to have a value of $100.5 billion, with a CAGR of 13.7% over the 2008-2013 period.
China is the leading country among the Top 5 emerging nations, with market revenues of $16.7 billion in 2007.
Why you should buy this report
Spot future trends and developments
Inform your business decisions
Add weight to presentations and marketing materials
Save time carrying out entry-level research
Market Definition
The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors).
(0 items)
